Eloxx Pharmaceuticals, Inc. | Uncategorized | Business Contracts

Description of Registered Securities (Filed With SEC on March 30, 2022)

Offer to Gregory Weaver from Eloxx Pharmaceuticals Ltd., dated September 11, 2017 (Filed With SEC on December 22, 2017)

Offer to Pedro Huertas from Eloxx Pharmaceuticals Ltd., dated April 17, 2015 (Filed With SEC on December 22, 2017)

Amendment to Agreement, dated as of November 23, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd (Filed With SEC on November 29, 2017)

Amendment to Agreement, dated as of August 1, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd (Filed With SEC on October 13, 2017)

SUBSCRIPTIONAGREEMENT (Filed With SEC on August 3, 2017)

AGREEMENT (Filed With SEC on June 6, 2017)

SEVIONTHERAPEUTICS, Inc. AMENDMENTTO ConsultingAgreement (Filed With SEC on May 12, 2016)

SUBSCRIPTIONAGREEMENT (Filed With SEC on October 9, 2015)

SEVIONTHERAPEUTICS, Inc. ConsultingAgreement (Filed With SEC on May 14, 2015)

SEVIONTHERAPEUTICS, Inc. ConsultingAgreement (Filed With SEC on February 17, 2015)

REVISEDBUDGET YEAR16 PERIOD:March 1, 2014 – August 31, 2014 (Filed With SEC on May 9, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 12, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 6, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 1, 2013)

Senesco Technologies, Inc. 721 Route 202/206 | Suite 130 | Bridgewater, NJ 08807 p 908 864 4444 | f 908 864 4440 www.senesco.com (Filed With SEC on September 11, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 9, 2013)

Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, New York 10004 (Filed With SEC on May 9, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 4, 2013)

AMENDMENT TO RESEARCHAGREEMENT (Filed With SEC on September 28, 2012)

SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on May 25, 2010)

Nondisclosure,Noncompetition and InventionAssignment Agreement (Filed With SEC on May 25, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 29, 2010)

[End of text.] (Filed With SEC on March 5, 2010)

SENESCOTECHNOLOGIES, INC. RESTRICTEDSTOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on November 16, 2009)

SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on September 28, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 30, 2009)

EXHIBIT10.2 SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 30, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 10, 2009)

SENESCO TECHNOLOGIES, INC. 2008 INCENTIVECOMPENSATION PLAN (Filed With SEC on February 17, 2009)

Proposal for Biodistribution and Repeat DoseToxicity Studies in Mice Submitted by: BioReliance 14920 Broschart Road Rockville, MD 20850 To: Cato Research Ltd. and Senesco... (Filed With SEC on November 14, 2008)

Confidential Treatment Requested under 17C.F.R. 200.80(b)(4) and240.24b-2 (Filed With SEC on September 26, 2008)

LICENSEAGREEMENT between BAYER CROPSCIENCE AG and SENESCOTECHNOLOGIES, INC. (Filed With SEC on November 14, 2007)

SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on September 28, 2007)

[INSERT H.C.WAINWRIGHT LETTERHEAD] (Filed With SEC on September 28, 2007)

STANFORD GROUPCOMPANY (Filed With SEC on October 13, 2006)

H. C .WAINWRIGHT &CO., lNC. Investments Since 1868 (Filed With SEC on October 13, 2006)

Eloxx Pharmaceuticals, Inc. (199) | Uncategorized (42)